See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Eurovision
Baseball
Social Media
Artificial Intelligence
South America
Vladimir Putin
NCAA
Natural Disasters
Donald Trump
Soccer
YouTube
Premier League
Published • loading... • Updated

In three patients, Rocket’s second heart gene therapy shows promise

Summary by Endpoints News
Rocket Pharmaceuticals reports early success in gene therapy trial for heart condition PKP2-ACM, with 3 patients showing improved heart function. One had severe side effects.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Endpoints NewsEndpoints News

In three patients, Rocket’s second heart gene therapy shows promise

Rocket Pharmaceuticals reports early success in gene therapy trial for heart condition PKP2-ACM, with 3 patients showing improved heart function. One had severe side effects.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Endpoints News broke the news in on Friday, May 16, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal